AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹78 Cr | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AARTI DRUGS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹71 Cr |
| Mar2022 | ₹72 Cr |
| Mar2021 | ₹77 Cr |
How is Deferred Tax Assets / Liabilities of AARTI DRUGS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹78 Cr | 3.34 | |
| Mar2024 | ₹76 Cr | 6.68 | |
| Mar2023 | ₹71 Cr | -2.02 | |
| Mar2022 | ₹72 Cr | -6.10 | |
| Mar2021 | ₹77 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,619.1 Cr | 4.4% | 6.6% | -18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 4.4% |
6.6% |
-18.2% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses